Concepedia

Lisa Rodríguez

LR

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2012

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Center for Devices and Radiological Health

Lisa Rodríguez is an author at United States Food and Drug Administration specializing in medicine, health sciences, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2012–2022

11

Publications

11

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 532 citations · Full text

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations

Lauretta Odogwu, Luckson Mathieu, Gideon M. Blumenthal et al. · The Oncologist · 2018 · 212 citations · Full text

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 170 citations

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions

Diana Bradford, Erin Larkins, Sirisha L. Mushti et al. · Clinical Cancer Research · 2020 · 161 citations

FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma

Abhilasha Nair, Kelie Reece, Martha Donoghue et al. · The Oncologist · 2020 · 81 citations · Full text

, , +14

1–5 of 11